Page 7 - Origin House News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IM Cannabis Corp.: IM Cannabis Reports Fiscal 2020 Results; Provides Preliminary Q1 Results and Q2 Outlook 1; FY 2020: revenues of $15.9 million and gross margin of 55% 1 . Preliminary unaudited Q1 2021 revenues expected to be in the range of $8.5 - $9.0 million; gross margin expected to be in the range of 50% to 55%. Q2 2021 revenues expected to be in the range of $17 million - $19 million from continued growth in Israel, resumption of product shipments and growth of revenue in Germany, and inclusion of Trichome operations in the Company s financial results TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / April 23, 2021 / IM Cannabis Corp. ( Company ) (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator (

United statesUnited kingdomState of israelCaitlin kasunichElizabeth barkerOren shusterGal wilderAdjupharm gmbhMarc lustigHerbs ltdCompany commonCanadian securities exchangeNutraceuticals incInternational financial reporting standardsPharmacielo ltdIm cannabis corp